GNS Healthcare Names Patrick Getzen, Chief Data and Analytics Officer of Blue Cross and Blue Shield of North Carolina, to its Strategic Advisory Board

CAMBRIDGE, Mass., Feb. 6, 2018 /PRNewswire/ -- GNS Healthcare (GNS), a leading precision medicine company, announced the appointment of Patrick Getzen, Chief Data and Analytics Officer of Blue Cross and Blue Shield of North Carolina (Blue Cross NC), to its Strategic Advisory Board (SAB).  

In his role at Blue Cross NC, Getzen focuses on data quality, stewardship and governance, as well as analytics enablement for the company. He leads technology-focused teams that are dedicated to ensuring the company's actions are efficient and information-driven.

"Patrick's expertise in utilizing data and technology to deliver value and precision to his stakeholders is at the forefront of health plan innovation. His unique perspective will be invaluable to GNS as we continue to build solutions that solve problems across the entire healthcare ecosystem," said Colin Hill, Chairman, CEO and co-founder of GNS Healthcare. "We are at a pivotal moment. Machine learning is transforming healthcare by matching the right intervention to the right patient at the right time. I can't think of a better time for Patrick to join our Strategic Advisory Board."

A graduate of the University of Maryland, Baltimore, with a degree in Mathematics, Getzen is also a Fellow of the Society of Actuaries and a Member of the American Academy of Actuaries. He is also a community health advocate and serves as a board member of Appalachian State University's Walker College of Business, Blue Health Intelligence, and the Caring Community Foundation.

"I have seen firsthand the toll that imprecise medicine takes on the healthcare system in this country," said Getzen. "GNS is poised to revolutionize how health plans interact with their members and providers by turning data into knowledge that eliminates wasteful spending and improves health outcomes. I'm excited to join the board during this period of shift to value-based care." 

GNS Healthcare's current SAB is comprised of leading researchers, clinicians and scientists including; Atul Butte, MD, PhD; Randy Krakauer, MD; Isaac Kohane, MD, PhD; Richard Popiel, MD, MBA and David Sontag PhD. A full list of GNS SAB members can be found on website here.

About REFS™
REFS™ (Reverse Engineering & Forward Simulation) is GNS Healthcare's patented causal learning and simulation platform. Unlike traditional artificial intelligence platforms, REFS analyzes data sets beyond correlation, instead inferring causal mechanisms between variables to answer questions such as: How will the patient respond to this treatment? What if we choose one intervention over another? REFS is the only commercially available platform that infers causal mechanisms from patient data at scale from traditional healthcare and emerging data sources to bring the promise of precision medicine within reach.

About GNS Healthcare
GNS Healthcare solves healthcare's matching problem for leading health plans, biopharma companies, and health systems. We transform massive and diverse data streams to precisely match therapeutics, procedures, and care management interventions to individuals, improving health outcomes and saving billions of dollars. Our causal learning and simulation platform, REFS, accelerates the discovery of what works for whom and why.

www.gnshealthcare.com

Media Contact:

Patty Kellicker
VP, Marketing
[email protected] 

SOURCE GNS Healthcare

Related Links

http://www.gnshealthcare.com